Hong Kong probes cosmetic injections made from human skin
By the AFREEQUE newsroom, based on Ang
Hong Kong authorities are investigating the illegal sale and administration of cosmetic injections made from human collagen obtained from cadavers. Inspections led to the seizure of around 100 vials and the arrest of a woman, while health authorities warned of infectious and immune risks, reports ANG.
Hong Kong health authorities have opened an investigation into the illegal marketing and administration of Elravie Re2O, a South Korean cosmetic injectable made from collagen derived from human cadavers, reports the ANG agency, citing Inforpress and Lusa. The product, presented as a cell regenerator, is not registered in the territory and may expose patients to pathogens or immune reactions.
Clinics and beauty salons offered the treatment without medical supervision while concealing its human origin. Three sessions could cost up to 15,000 Hong Kong dollars, or about 1,700 euros. The Department of Health and police have intensified inspections in several districts, seizing nearly 100 vials of regulated substances and dozens of unauthorised injectables. A woman was arrested, according to ANG.
Hong Kong legislation on organ transplants and pharmaceutical products regulates this type of substance and provides for up to two years in prison for its illegal sale. Elravie Re2O is a micronised acellular human dermal matrix composed of 89% collagen, elastin and other proteins. Specialists nevertheless warn that its treatment does not guarantee the complete removal of the original cellular material, with risks of infection, immune rejection and variable quality depending on the donor.
Developed by South Korean company L&C Bio, the product is distributed in South Korea, Japan and Singapore, as well as irregularly in the United States. The company plans to apply for official US authorisation in 2027. The product is currently not authorised in mainland China, Taiwan or the United Kingdom, while South Korea’s regulator is examining changes to legislation on the cosmetic use of human tissue.
